阅读器YTHDF1通过以A依赖的方式通过调节费里介导铁死来促进肺癌的进展
Hongtao Diao1,2, Huiling Tan1,2, Yaju Hu1,2
1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Pharmaceuticals (Basel, Switzerland)
|June 1, 2023
概括
高表达YTHDF1通过增加费里翻译促进肺癌. 击败YTHDF1抑制癌细胞生长并诱导铁亡,提供了一个潜在的新治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- N6-甲基氨酸 (m6A) 是一个关键的表观遗传调节剂,参与癌症进展.
- 作为一个"读者"的YTHDF1,在各种癌症中影响mRNA修饰和蛋白质翻译.
- 在肺癌中YTHDF1的特定作用仍然不完全理解.
研究的目的:
- 研究YTHDF1在肺癌发展中的功能.
- 阐明YTHDF1在肺癌发生过程中的潜在分子机制.
- 根据YTHDF1的作用,确定肺癌的潜在治疗点.
主要方法:
- 在肺癌组织中分析YTHDF1表达.
- 肺癌细胞系中的功能丧失实验 (YTHDF1敲击).
- 功能性测试用于评估细胞增殖,迁移,入侵和铁亡.
- 使用功能性测试识别YTHDF1目标.
主要成果:
- 在肺癌中,YTHDF1的表达显著上调.
- 抑制YTHDF1可以抑制肺癌细胞的增殖,迁移和入侵.
- YTHDF1 knockdown 诱导肺癌细胞中的铁亡.
- 费里丁 (FTH) 被确定为YTHDF1的直接标,YTHDF1加速其翻译.
- 过度表达FTH部分扭转了YTHDF1耗尽的抑制作用.
结论:
- 调节后的YTHDF1通过以A-依赖的方式增强费里翻译来促进肺癌的进展.
- 抑制YTHDF1代表了肺癌的潜在治疗策略.
- 针对YTHDF1-ferritin轴可以为肺癌诊断和治疗提供新的途径.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


